Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurogranin is an intrinsically unstructured, postsynaptic protein highly expressed in the brain, especially in dendritic spines of pyramidal cells of the hippocampus and cortex[2][3][4]. It binds calmodulin through its IQ motif in a calcium-sensitive manner and is a substrate for protein kinase C, which modulates its association with calmodulin[1][2][4][6]. By regulating calmodulin availability, neurogranin plays a pivotal role in intracellular calcium signaling, synaptic plasticity, long-term potentiation, and thus learning and memory formation. Its gene, NRGN, is controlled in part by thyroid hormones. Clinical investigations highlight neurogranin's altered expression in multiple neuropsychiatric and neurodegenerative diseases, making it a candidate biomarker for disease state and progression[1][2][3][4][5][6]. Although its primary molecular role is as a signaling modulator, neurogranin's concentration in cerebrospinal fluid is being developed as a diagnostic and prognostic tool for synaptic dysfunction and neurodegeneration, especially Alzheimer's disease.
For drugs targeting neurogranin (hypothetical/exploratory): - Modulation of neurogranin–calmodulin binding, affecting calcium signaling and synaptic activity - Altering phosphorylation by protein kinase C to influence synaptic strength - Regulation of N-methyl-D-aspartate receptor (NMDAR)-dependent plasticity and signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurogranin (protein kinase C substrate) (NRGN).